Mc Ilrath & Eck, LLC Oramed Pharmaceuticals Inc. Transaction History
Mc Ilrath & Eck, LLC
- $574 Million
- Q3 2024
A detailed history of Mc Ilrath & Eck, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Mc Ilrath & Eck, LLC holds 1,000 shares of ORMP stock, worth $2,380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 2,000
50.0%
Holding current value
$2,380
Previous $5,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ORMP
# of Institutions
63Shares Held
7.4MCall Options Held
4KPut Options Held
2.1K-
Bml Capital Management, LLC Zionsville, IN2.19MShares$5.2 Million3.14% of portfolio
-
Murchinson Ltd. Toronto, A61.71MShares$4.07 Million1.22% of portfolio
-
Boothbay Fund Management, LLC New York, NY828KShares$1.97 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$872,0342.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$689,7310.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $92.4M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...